|
1
|
Tomonori K, Hiroshi O, Toyoda K and
Kitajima K: Brain gadolinium deposition after administration of
gadolinium-based contrast agents. Jpn J Radiol. 34:3–9.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sherry AD, Caravan P and Lenkinski RE: A
primer on gadolinium chemistry. J Magn Reson Imaging. 30:1240–1248.
2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Thomsen HS, Morcos SK, Almen T, Almén T,
Bellin MF, Bertolotto M, Bongartz G, Clement O, Leander P,
Heinz-Peer G, Reimer P, et al: Nephrogenic systemic fibrosis and
gadolinium-based contrast media: Updated ESUR Contrast Medium
Safety Committee guidelines. Eur Radiol. 23:307–318.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bellin MF: MR contrast agents, the old and
the new. Eur J Radiol. 60:314–323. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Niendorf HP, Alhassan A and Balzer TH:
Safety and risk of gadolinium-DTPA: Extended clinical experience
after more than 20 million applications. Magn Monograph. 1–38.
1998.
|
|
6
|
Granata V, Cascella M, Fusco R,
dell'Aprovitola N, Catalano O, Filice S, Schiavone V, Izzo F, Cuomo
A, Petrillo A, et al: Immediate adverse reactions to
gadolinium-based MR contrast media: A retrospective analysis on
10.608 examinations. Biomed Res Int. 2016(3918292)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Runge VM, Ai T, Hao D and Hu X: The
developmental history of the gadolinium chelates as intravenous
contrast media for magnetic resonance. Invest Radiol. 46:807–816.
2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Runge VM, Steward RG, Clanton JA, Jones
MM, Lukehart CM, Partain CL and James AE Jr: Work in progress:
Potential oral and intravenous paramagnetic NMR contrast agents.
Radiology. 147:789–791. 1983.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hao D, Ai T, Goerner F, Hu X, Runge VM and
Tweedle M: MRI contrast agents: Basic chemistry and safety. J Magn
Reson Imaging. 36:1060–1071. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
The American College of Radiology. Manual
on Contrast Media Version. Version 10.3.2018. Accessed from:
http://www.acr.org/.
|
|
11
|
Ersoy H and Rybicki FJ: Biochemical safety
profiles of gadolinium-based extracellular contrast agents and
nephrogenic systemic fibrosis. J Magn Reson Imaging. 26:1190–1197.
2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Brănișteanu DE, Pintilie A, Dimitriu A,
Cerbu A, Ciobanu D, Oanta A and Tatu AL: Clinical, laboratory and
therapeutic profile of lichen planus. Medical Surgical J.
121:25–32. 2017.
|
|
13
|
Tatu AL, Ciobotaru OR, Miulescu M, Buzia
OD, Elisei AM, Mardare N, Diaconu C, Robu S and Nwabudike LC:
Hydrochlorothiazide: Chemical structure, therapeutic, phototoxic
and carcinogenetic effects in dermatology. Rev Chim. 69:2110–2114.
2018.
|
|
14
|
Fekete GL and Fekete L: Cutaneous
leukocytoclastic vasculitis associated with erlotinib treatment: A
case report and review of the literature. Exp Ther Med.
17:1128–1131. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ciobotaru OR, Lupu MN, Rebegea L,
Ciobotaru OC, Earar K and Miulescu M: Dexamethasone-chemical
structure and mechanisms of action in prophylaxis of postoperative
side effects. Rev Chim. 70:843–847. 2019.
|
|
16
|
Tatu AL and Cristea VC: Unilateral
blepharitis with fine follicular scaling. J Cutan Med Surg.
21(442)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lupu M, Miulescu M, Sandu MN, Filip I,
Rebegea L, Ciobotaru O, Stoleriu G, Earar K, Voinecsu CD, Oana R
and Ciobotaru OR: Cannabinoids: Chemical structure, mechanisms of
action, toxicity and implications in everyday life. Rev Chim.
70(627)2019.
|
|
18
|
Nwabudike LC, Elisei AM, Buzia OD,
Miulescu M and Tatu AL: Statins. A review on structural
perspectives, adverse reactions and relations with non-melanoma
skin cancer. Rev Chim. 69:2557–2562. 2018.
|
|
19
|
Ardeleanu V, Dobre M and Georgescu AM:
Deep facial wrinkle treatment outcome after first injection of
reticulated hyaluronic acid. Rev Chim. 66:2129–2131. 2015.
|
|
20
|
Nwabudike L and Tatu AL: Response to -
chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32(e159)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tatu AL, Ionescu MA and Nwabudike LC:
Contact allergy to topical mometasone furoate confirmed by
rechallenge and patch test. Am J Ther. 25:e497–e498.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Neurofibromatosis. Conference statement.
National Institutes of Health Consensus Development Conference.
Arch Neurol. 45:575–578. 1988.
|
|
23
|
Antônio JR, Goloni-Bertollo EM and Trídico
L: Neurofibromatosis: Chronological history and current issues. An
Bras Dermatol. 88:329–343. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tatu AL and Nwabudike LC: The treatment
options of male genital lichen sclerosus et atrophicus short title
for a running head: Treatments of Genital Lichen Sclerosus
Conference: 14th National Congress of Urogynecology
(Urogyn)Location: Eforie, Romania Date: SEP 07-09, 2017.
Proceedings of the 14th national congress of Urogynecology and the
national conference of the Romanian association for the study of
pain, pp262-264, 2017.
|
|
25
|
Nica SC, Mihailescu G, Nica SM, Baetu C,
Clatici VG and Buruga I: Neurofibromatosis-one disease for a
multidisciplinary team. RoJCED. 3:38–49. 2016.
|
|
26
|
Lund AM and Skobby F: Optic gliomas in
children with neurofibromatosis type 1. Eur J Pediatr. 150:835–838.
1990.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Elster AD: Radiologic screening in
neurocutaneous syndromes: Strategies and controversies. AJNR Am J
Neuroradiol. 13:1078–1082. 1992.PubMed/NCBI
|
|
28
|
Truhan AP and Filipek PA: Magnetic
resonance imaging: Its role in the neuroradiologic evaluation of
neurofibromatosis, tuberous sclerosis and Sturge-Weber syndrome.
Arch Dermatol. 129:219–226. 1993.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bognanno JR, Edwards MK, Lee TA, Dunn DW,
Roos KL and Klatte EC: Cranial MR imaging in neurofibromatosis. Am
J Roentgenol. 151:381–388. 1988.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bonawitz C, Castillo M, Chin CT, Mukherji
SK and Barkovich AJ: Usefulness of contrast material in MR of
patients with Neurofibromatosis type 1. AJNR Am J Neuoradiol.
19:541–546. 1998.PubMed/NCBI
|
|
31
|
Tatu AL: Umbilicated blue black lesion on
the lateral thorax. J Cutan Med Surg. 21(252)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ardeleanu V, Frincu LL and Georgescu C:
Neoangiogenesis-assessment in esophageal adenocarcinomas. Indian J
Surg. 77 (Suppl 3):S971–S976. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ardeleanu V, Chebac GR, Georgescu C, Vesa
D, Frâncu L, Frîncu LD and Păduraru D: The modifications suffered
by the peri-esophageal anatomical structures in the hiatal hernia
disease: A qualitative and quantitative microanatomic study. Rom J
Morphol Embryol. 51:765–770. 2010.PubMed/NCBI
|
|
34
|
Fekete GL and Fekete JE: Steatocystoma
multiplex generalizata partial suppurativa-case report. Acta
Dermatovenerol Croat. 18:114–119. 2010.PubMed/NCBI
|
